Belfast · Northern Ireland
TheBELFAST HERALDLocal knowledge. National perspective.
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works
HealthPremium archive

National Medical Products Administration approves China's first mixed-COVID-19 vaccine trial combining the CoronaVac vaccine made by Sinovac and the DNA-based vaccine…

The National Medical Products Administration approves China's first mixed-COVID-19 vaccine trial combining the CoronaVac vaccine made by Sinovac and the DNA-based vaccine made by Inovio.

By Belfast Herald Newsdesk1 min read

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthNational Medical Products Administration approves China's first mixed-COVID-19 vaccine trial combining the CoronaVac vaccine made by Sinovac and the DNA-based vaccine…

The National Medical Products Administration approves China's first mixed-COVID-19 vaccine trial combining the CoronaVac vaccine made by Sinovac and the DNA-based vaccine made by Inovio.

View Premium plansBrowse free archive reports